2022 journal article

Identifying patient-level risk factors associated with non-beta-lactam resistance outcomes in invasive MRSA infections in the United States using chain graphs

JAC-ANTIMICROBIAL RESISTANCE, 4(4).

By: W. Love n, C. Wang n & C. Lanzas n 

TL;DR: The differences in resistance phenotypes between patients with previous healthcare use or positive blood cultures, or from different states, may be useful to inform first-choice antibiotics to treat clinical MRSA cases. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: July 11, 2022

Abstract